Market News: FDA Approves Dexcom’s Stelo Glucose Biosensor System as the First over-the-counter continuous glucose monitor for children

Dexcom’s Stelo Glucose Biosensor System is now indicated for children ages 2+ who do not use insulin, expanding access to glucose monitoring. Read more about the rest of the Pharmacy500 in the news in our Weekly Dose newsletter!